private:miracormedicalsystemsgmbh
|
874703
|
May 30th, 2019 12:00AM
|
Miracor Medical SA
|
613
|
29.00
|
Open
|
Medical Devices
|
May 29th, 2019 08:36PM
|
May 29th, 2019 08:36PM
|
Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding.
|
Open
|
medical device, cardiology, cardiac surgery, marketing, sales, product development
|
Open
|
Rue de Bruxelles 174
|
Hognoul
|
Walloon Region
|
BE
|
4342
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 17th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 16th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 15th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 14th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 13th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 12th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 11th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 10th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|
private:miracormedicalsystemsgmbh
|
874703
|
Feb 9th, 2018 12:00AM
|
Miracor Medical Systems GmbH
|
390
|
26.00
|
Open
|
Medical Devices
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and commercializes the CE-marked PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Pre-Clinical and Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further post-market clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed two financing rounds raising a double-digit Million Euro amount in venture capital and public funding.
|
|
|
|
|
|
|
|
|
|
Miracor Medical Systems GmbH
|
|
Health Care Equipment & Services
|